INS and metabolic dysfunction-associated steatotic liver disease: While some beneficial effects of HIF activation have been noted, such as a potential role in improving insulin sensitivity, on balance, HIF activation appears to be harmful in NAFLD, and may therefore be a useful therapeutic target.